MP16-05: Beyond the Tumor: Exploring the Financial Toxicity of Non-Muscle Invasive Bladder Cancer in a diverse, urban population
Friday, May 3, 2024 1:00 PM to 3:00 PM · 2 hr. (US/Central)
221B
Abstract
Information
Full Abstract and Figures
Author Block
Julia Nadelmann*, Andrewe Baca, Priya Dave, Alexander Small, Alexander Sankin, New York, NY
Introduction
Financial Toxicity (FT) describes the negative impact of disease treatment-related costs that affect patients’ quality of life (QoL), including direct costs and associated indirect costs such as transportation, childcare and missed days of work. Non-muscle invasive bladder cancer (NMIBC) is among the costliest cancers due to the need for long term surveillance. Thus, gaining a better understanding of FT is paramount. While existing literature reports on FT of NMIBC in predominantly Caucasian patients, we sought to characterize FT of NMIBC among our institution’s uniquely diverse, urban population.
Methods
We surveyed a cohort of patients at our institution with NMIBC using the validated COST tool (COmprehensive Score for financial Toxicity). Scores are inversely correlated to the degree of FT. Scores of 25-14 indicate “Moderate FT” and <14 indicate “Severe FT”. Demographic and disease specific information were collected. Descriptive statistics, X2 tests, T Tests, Spearman correlation, and logistic regression were performed using SPSS.
Results
64 patients with NMIBC were surveyed. The median age was 74 years (IQR, 64-80). 45% were female; 42% identified as Caucasian, 30% as Black, and 28% as Hispanic. The median COST score was 23.2 (IQR,15-32). 59% of patients reported at least moderate FT (COST score = 25). 36% reported severe FT (COST score <14). Black patients were more likely to experience at least moderate FT than Caucasians (79% vs 33%, p < 0.05). Caucasian patients had a mean COST score 9 points higher than all other races combined (p < 0.01).Overall median household income was $38,000 (IQR,$20,000-$72500), and increasing income had a significant positive correlation between with COST score (Pearson’s R = 0.469, p < 0.001). Risk factors for FT included non-Caucasian race, and lower education level (Table 1).
Conclusions
In a diverse, urban population, rates of FT among NMIBC patients were higher than previously reported. FT may disproportionately affect non-Caucasian patients and may be related to decreased access to care. These results highlight the need to further assess and address FT in NMIBC patients.
Source Of Funding
No funding was provided for this project
Author Block
Julia Nadelmann*, Andrewe Baca, Priya Dave, Alexander Small, Alexander Sankin, New York, NY
Introduction
Financial Toxicity (FT) describes the negative impact of disease treatment-related costs that affect patients’ quality of life (QoL), including direct costs and associated indirect costs such as transportation, childcare and missed days of work. Non-muscle invasive bladder cancer (NMIBC) is among the costliest cancers due to the need for long term surveillance. Thus, gaining a better understanding of FT is paramount. While existing literature reports on FT of NMIBC in predominantly Caucasian patients, we sought to characterize FT of NMIBC among our institution’s uniquely diverse, urban population.
Methods
We surveyed a cohort of patients at our institution with NMIBC using the validated COST tool (COmprehensive Score for financial Toxicity). Scores are inversely correlated to the degree of FT. Scores of 25-14 indicate “Moderate FT” and <14 indicate “Severe FT”. Demographic and disease specific information were collected. Descriptive statistics, X2 tests, T Tests, Spearman correlation, and logistic regression were performed using SPSS.
Results
64 patients with NMIBC were surveyed. The median age was 74 years (IQR, 64-80). 45% were female; 42% identified as Caucasian, 30% as Black, and 28% as Hispanic. The median COST score was 23.2 (IQR,15-32). 59% of patients reported at least moderate FT (COST score = 25). 36% reported severe FT (COST score <14). Black patients were more likely to experience at least moderate FT than Caucasians (79% vs 33%, p < 0.05). Caucasian patients had a mean COST score 9 points higher than all other races combined (p < 0.01).Overall median household income was $38,000 (IQR,$20,000-$72500), and increasing income had a significant positive correlation between with COST score (Pearson’s R = 0.469, p < 0.001). Risk factors for FT included non-Caucasian race, and lower education level (Table 1).
Conclusions
In a diverse, urban population, rates of FT among NMIBC patients were higher than previously reported. FT may disproportionately affect non-Caucasian patients and may be related to decreased access to care. These results highlight the need to further assess and address FT in NMIBC patients.
Source Of Funding
No funding was provided for this project